Improving the Sleep and Circadian Rhythms of Mechanically Ventilated Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01284140 |
Recruitment Status
:
Completed
First Posted
: January 26, 2011
Last Update Posted
: February 26, 2018
|
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Critical Illness Sleep Deprivation Respiratory Failure Sleep Disorders, Circadian Rhythm | Behavioral: Sleep and circadian rhythm promotion Behavioral: Usual care | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 24 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Improving the Sleep and Circadian Rhythms of Mechanically Ventilated Patients |
Study Start Date : | January 2011 |
Actual Primary Completion Date : | December 2016 |
Actual Study Completion Date : | December 2016 |
Arm | Intervention/treatment |
---|---|
Experimental: Sleep promotion protocol
Behavioral: sleep and circadian rhythm promotion including timed light exposure.
|
Behavioral: Sleep and circadian rhythm promotion
This multifaceted intervention will attempt to enhance sleep and circadian rhythmicity through improved scheduling of nursing procedures, enforcement of a day/night routine, increased light exposure during the day, and decreased light and sound exposure during the night. Supplemental bright lights and eyeshades and noise cancelling headphones may also be employed.
|
Active Comparator: Usual care
Behavioral: usual care.
|
Behavioral: Usual care
Usual care.
|
- Circadian timing [ Time Frame: Day 3 ]The magnitude of the phase change in 6-sulfatoxymelatonin excretion between Day 1 and Day 3 will be compared between the intervention and usual care groups.
- Normal circadian timing [ Time Frame: Day 3 ]The percentage of subjects who exhibit normal circadian timing of 6-sulfatoxymelatonin excretion on Day 3 will be compared between the intervention and usual care groups.
- Circadian amplitude [ Time Frame: Day 3 ]The amplitude of the circadian rhythm of 6-sulfatoxymelatonin on Day 3 will be compared between the usual care and intervention groups.
- Spectral edge frequency 95% [ Time Frame: Day 2 ]The difference between the polysomnographically derived daytime and nocturnal spectral edge frequency 95% parameter will be used as a measure of increased diurnal sleep/wake activity. This parameter will be compared between the usual care and intervention groups.
- Delirium [ Time Frame: Day 3 ]The percentage of patients who are delirious at the conclusion at the study will be compared between the intervention and usual care groups.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age 18 years or older
- Receiving mechanical ventilation and intravenous sedation
Exclusion Criteria:
- Debilitating central nervous system disease or degenerative disorder
- Active seizures
- Persistent coma
- Renal failure requiring dialysis
- Expected to be extubated within 24 hours
- Currently receiving neuromuscular blocker

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01284140
United States, Illinois | |
University of Chicago Medical Center | |
Chicago, Illinois, United States, 60637 | |
United States, Iowa | |
University of Iowa Hospitals and Clinics | |
Iowa City, Iowa, United States, 52242 |
Principal Investigator: | Brian K Gehlbach, MD | University of Iowa |
Responsible Party: | Brian Gehlbach, Associate Professor, University of Iowa |
ClinicalTrials.gov Identifier: | NCT01284140 History of Changes |
Other Study ID Numbers: |
201105754 5K23HL088020 ( U.S. NIH Grant/Contract ) |
First Posted: | January 26, 2011 Key Record Dates |
Last Update Posted: | February 26, 2018 |
Last Verified: | February 2018 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Keywords provided by Brian Gehlbach, University of Iowa:
Critical illness Sleep Polysomnography |
Respiratory failure Circadian rhythm Sedation |
Additional relevant MeSH terms:
Respiratory Insufficiency Critical Illness Sleep Wake Disorders Parasomnias Sleep Deprivation Sleep Disorders, Circadian Rhythm Respiration Disorders Respiratory Tract Diseases Disease Attributes |
Pathologic Processes Nervous System Diseases Neurologic Manifestations Signs and Symptoms Mental Disorders Dyssomnias Chronobiology Disorders Occupational Diseases |